Breaking News: NovoNutrients Secures Funding to Revolutionize CO2 Conversion Process
Tuesday, 9 July 2024, 20:55
Breaking News: NovoNutrients Secures Funding to Revolutionize CO2 Conversion Process
In a groundbreaking move, NovoNutrients has secured $18 million in Series A funding to build a pilot-scale facility and demonstrate the efficiency of its innovative fermentation process.
Key Points:
- Investment: $18 million raised in Series A round
- Goal: Convert CO2 into protein for human and pet consumption
- Impact: Significant step towards sustainable protein production
The company's utilization of bugs in the conversion process highlights a novel approach towards addressing environmental challenges.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.